Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
Robert B. Hegeman, MD close
EIDPavjj_Gs
Robert B. Hegeman, MD
 

Robert B. Hegeman, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Hegeman did his undergraduate training at University of Kansas, and went on to complete medical school at University of Kansas School of Medicine, where he received the Delp Award for Compassion in Medicine. He completed his Internal Medicine residency at Medical College of Wisconsin in Milwaukee, where he was appointed Chief Resident. He completed a Medical Oncology Fellowship in the summer of 2005 at the University of Wisconsin Carbone Cancer Center Medicine and is board certified in Medical Oncology. He sees a range of hematology and oncology patients and is a member of the UW Health Breast Center.

Specialties

Hematology

Medical Oncology

UW Health Clinics

1 S. Park Clinic
(608) 287-2933 | Map
1 S. Park Clinic
(608) 287-2552 | (888) 703-2778 | Map

Other Locations

Monroe Clinic (Monroe)
(608) 324-2685 |  Map

Hospital Affiliation(s)

Meriter Hospital (primary)

Languages Spoken

English
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Internal Medicine
Medical Oncology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency Medical College of Wisconsin
Internship Medical College of Wisconsin
Medical School University of Kansas School of Medicine, Kansas City, KS, 1994

Awards/Honors

UW Health Patient Experience Physician Champion Award 2013


Procedures

Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions

PubMed Articles
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S . Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Burkard ME Wisinski KB Njiaju UO Donohue S Hegeman R Stella A Mansky P Shah V Goggins T Qamar R Dietrich L Kim K Traynor AM Tevaarwerk AJ . Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study. Clin Breast Cancer. 2014 Jun;14(3):205-11
[PubMed ID: 24342730]
Hegeman RB Liu G Wilding G McNeel DG . Newer therapies in advanced prostate cancer. Clin Prostate Cancer. 2004 Dec;3(3):150-6
[PubMed ID: 15636681]